Intrafamilial Helicobacter Pylori Infection in Hong Kong

Launched by CHINESE UNIVERSITY OF HONG KONG · May 20, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Intrafamilial Helicobacter Pylori Infection in Hong Kong," is looking to understand how the bacteria H. pylori spreads within families and what factors might increase this risk among household members. H. pylori is a common bacteria that can cause stomach issues, and the study aims to gather information on how often it spreads in homes, especially since current guidelines suggest not testing family members of infected individuals in Hong Kong. By learning more about this, the researchers hope to improve strategies for managing H. pylori infections and reducing related health problems in the community.

To be eligible for this study, participants need to be adults aged 18 or older who have been diagnosed with an H. pylori infection through specific tests. People who cannot undergo a certain breath test or have recently taken antibiotics or other medications that affect the stomach are not eligible. Those who join the trial will help researchers gather valuable information while contributing to future healthcare policies regarding H. pylori management in Hong Kong. The study has not started recruiting participants yet, but it promises to shed light on important family health issues related to this infection.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults age\>=18 years of age
• • For H. pylori infected patients only: Diagnosed to have H. pylori infection by either histology, rapid urease test or urea breath test
• • Written informed consent obtained
• Exclusion Criteria:
• • Unable to perform urea breath test
• • Contraindications for urea breath test
• • Used antibiotics within the past month/proton pump inhibitors within two weeks